MIVI Neuroscience

Eden Prairie, United States Founded: 2013 • Age: 13 yrs
Catheters and devices for acute ischemic stroke treatment are developed.

About MIVI Neuroscience

MIVI Neuroscience is a company based in Eden Prairie (United States) founded in 2013.. MIVI Neuroscience has raised $66.48 million across 10 funding rounds from investors including Perceptive Advisors, Deerfield and Aphelion Capital. The company has 37 employees as of December 31, 2021. MIVI Neuroscience offers products and services including Q Aspiration Catheter and DAISe Thrombectomy System. MIVI Neuroscience operates in a competitive market with competitors including Conformal Medical, MicroTransponder, Perfuze, Wallaby Medical and BrainQ, among others.

  • Headquarter Eden Prairie, United States
  • Employees 37 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Mivi Neuroscience, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $66.48 M (USD)

    in 10 rounds

  • Latest Funding Round
    $10 M (USD), Series C

    Jul 31, 2023

  • Investors
  • Employee Count
    37

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MIVI Neuroscience

MIVI Neuroscience offers a comprehensive portfolio of products and services, including Q Aspiration Catheter and DAISe Thrombectomy System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Catheter designed for enhanced flow rates in clot removal procedures

System for mechanical clot retrieval and reducing embolization risks

People of MIVI Neuroscience
Headcount 10-50
Employee Profiles 4
Board Members and Advisors 5
Employee Profiles
People
Tim Hauch
CFO
People
Bob Colloton
CEO

Unlock access to complete

Board Members and Advisors
people
Craig Yeshion
Board Member
people
Taylor Whitman
Member Board Of Directors
people
Chris Dewey
Board Member

Unlock access to complete

Funding Insights of MIVI Neuroscience

MIVI Neuroscience has successfully raised a total of $66.48M across 10 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Series C — $10.0M
  • First Round

    (17 Mar 2017)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2023 Amount Series C - MIVI Neuroscience Valuation

investors

Jan, 2021 Amount Series B - MIVI Neuroscience Valuation

investors

Dec, 2020 Amount Series B - MIVI Neuroscience Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in MIVI Neuroscience

MIVI Neuroscience has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Perceptive Advisors, Deerfield and Aphelion Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Health-tech companies are targeted for venture capital investments.
Founded Year Domain Location
Healthcare ecosystem is supported through investment and innovation by Deerfield.
Founded Year Domain Location
Tech and life sciences focused VC firm investing in geographies such as the US
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by MIVI Neuroscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - MIVI Neuroscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Mivi Neuroscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of MIVI Neuroscience

MIVI Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Conformal Medical, MicroTransponder, Perfuze, Wallaby Medical and BrainQ, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Stroke prevention device for atrial fibrillation patients is developed.
domain founded_year HQ Location
Neurostimulation for chronic pain management, tinnitus treatment and post-stroke rehabilitation
domain founded_year HQ Location
A medical device for acute ischemic stroke treatment is developed.
domain founded_year HQ Location
A medical device for stroke treatment is developed.
domain founded_year HQ Location
AI-powered electromagnetic stimulation technology for stroke recovery is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Mivi Neuroscience

Frequently Asked Questions about MIVI Neuroscience

When was MIVI Neuroscience founded?

MIVI Neuroscience was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Where is MIVI Neuroscience located?

MIVI Neuroscience is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.

Is MIVI Neuroscience a funded company?

MIVI Neuroscience is a funded company, having raised a total of $66.48M across 10 funding rounds to date. The company's 1st funding round was a Series B of $45M, raised on Mar 17, 2017.

How many employees does MIVI Neuroscience have?

As of Dec 31, 2021, the latest employee count at MIVI Neuroscience is 37.

What does MIVI Neuroscience do?

MIVI Neuroscience was founded in 2013 in Eden Prairie, United States, focusing on medical devices within the neuroscience sector. Solutions for acute ischemic stroke are developed through collaboration with physicians, emphasizing neurovascular access, revascularization, and procedural protection in interventional neuroradiology. The proprietary platform is utilized to support safety and efficacy during these treatments.

Who are the top competitors of MIVI Neuroscience?

MIVI Neuroscience's top competitors include MicroTransponder, Perfuze and Conformal Medical.

What products or services does MIVI Neuroscience offer?

MIVI Neuroscience offers Q Aspiration Catheter and DAISe Thrombectomy System.

Who are MIVI Neuroscience's investors?

MIVI Neuroscience has 4 investors. Key investors include Perceptive Advisors, Deerfield, Aphelion Capital, and CHP Merger Corp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available